Association of apolipoprotein A1-CIII genetic polymorphism with plasma lipid concentration and coronary artery disease.

被引：0
|
作者：
Wu, JH [1 ]
Lo, SK [1 ]
Wen, MS [1 ]
Chern, MS [1 ]
Kao, JT [1 ]
Ko, LH [1 ]
机构：
[1] NATL TAIWAN UNIV,SCH MED,DEPT MED TECHNOL,TAIPEI,TAIWAN
来源：
MOLECULAR BIOLOGY OF THE CELL | 1996年 / 7卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1738 / 1738
页数：1
相关论文
共 50 条
  • [31] Angiotensin-I-converting enzyme (ACE) insertion/deletion polymorphism in Mexican patients with coronary artery disease.: Association with the disease but not with lipid levels
    Vargas-Alarcon, Gilberto
    Zamora, Jose
    Sanchez-Garcia, Sergio
    Rodriguez-Perez, Jose Manuel
    Cardoso, Guillermo
    Posadas-Romero, Carlos
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (02) : 131 - 135
  • [32] Apo CIII (SstI) polymorphism and its relation with coronary artery disease in North Indians
    Rai, H.
    Kumar, S.
    Sharma, A. K.
    Mastana, S.
    Kapoor, A.
    Pandey, C. M.
    Agrawal, S.
    Sinha, N.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S93 - S94
  • [33] Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia
    Pitsavos, C
    Choumerianou, DM
    Skoumas, J
    Maumus, S
    Stefanadis, C
    Dedoussis, GVZ
    Visvikis-Siest, S
    CLINICAL AND EXPERIMENTAL MEDICINE, 2005, 5 (04) : 196 - 201
  • [34] Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia
    C. Pitsavos
    D. M. Choumerianou
    J. Skoumas
    S. Maumus
    C. Stefanadis
    G. V. Z. Dedoussis*
    S. Visvikis-Siest*
    Clinical and Experimental Medicine, 2005, 5 : 196 - 201
  • [35] Association between the Xba I polymorphism of APOB gene and plasma lipid level in Mexican patients with coronary artery disease
    Gallegos-Arreola, Martha P.
    Valdez, Yadira
    Zuniga-Corona, Marco
    Figuera, Luis E.
    Arnaud-Lopez, Lisette
    Robles-Cervantes, Jose A.
    Gonzalez-Ortiz, Manuel
    Martinez-Abundis, Esperanza
    Puebla-Perez, Ana M.
    Zuniga-Gonzalez, Guillermo M.
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2012, 21 (02) : 312 - 318
  • [36] PLASMA APOLIPOPROTEIN(A), APOLIPOPROTEIN-A-I, APOLIPOPROTEIN-A-II, APOLIPOPROTEIN-B, APOLIPOPROTEIN-E AND APOLIPOPROTEIN-CIII CONTAINING PARTICLES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE
    GENEST, JJ
    BARD, JM
    FRUCHART, JC
    JENNER, JL
    ORDOVAS, JM
    WILSON, PWF
    SCHAEFER, EJ
    CIRCULATION, 1990, 82 (04) : 621 - 621
  • [37] Apolipoprotein E polymorphism, paraoxonase-1 activity and coronary artery disease: Is there a link
    Nabatchian, F.
    Khaghani, Sh.
    Miri, R.
    Mahmoodi, M.
    Karimi, A.
    Pasalar, R.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2008, 24 (02) : 204 - 208
  • [38] Association of apolipoprotein E genotype with serum insulin and lipid levels in men with coronary artery disease
    Jang, YS
    Park, HY
    Chae, JS
    Lee, JH
    FASEB JOURNAL, 2001, 15 (04): : A638 - A638
  • [39] Increased plasma lipid-poor apolipoprotein A-I in patients with coronary artery disease
    Suzuki, M
    Wada, H
    Maeda, S
    Saito, K
    Minatoguchi, S
    Saito, K
    Seishima, M
    CLINICAL CHEMISTRY, 2005, 51 (01) : 132 - 137
  • [40] Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
    Katzmann, Julius L.
    Werner, Christian M.
    Stojakovic, Tatjana
    Maerz, Winfried
    Scharnagl, Hubert
    Laufs, Ulrich
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
12345